SCHEMBL23787730

SCHEMBL23787730

CCCc1cc(-c2ccc(/N=N/c3c(S(=O)(=O)O)cc4ccccc4c3N)c(CCC)c2)ccc1/N=N/c1c(S(=O)(=O)O)cc2ccccc2c1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 4/20 0.46
▸ PHLPP2 Q6ZVD8 2/20 0.44
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ THRB P10828 4/20 0.43
▸ HPGD P15428 3/20 0.43
▸ RECQL P46063 3/20 0.43
▸ APP P05067 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ SNCA P37840 2/20 0.43
▸ BLM P54132 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ ALOX12 P18054 2/20 0.43
▸ SUMO2 P61956 3/20 0.43
▸ SUMO1 P63165 3/20 0.43
▸ SENP7 Q9BQF6 3/20 0.43
▸ SENP2 Q9HC62 3/20 0.43
▸ SENP1 Q9P0U3 3/20 0.43
▸ SENP3 Q9H4L4 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787548 0.92 ENPP2 (0.48) ENPP2PHLPP2MEN1KMT2AALDH1A1
SCHEMBL23787794 0.88 PHLPP2 (0.52) ENPP2PHLPP2MEN1KMT2AALDH1A1
SCHEMBL23787630 0.85 ALDH1A1 (0.42) ENPP2PHLPP2MEN1KMT2AALDH1A1
SCHEMBL23787679 0.84 ALDH1A1 (0.44) ENPP2PHLPP2MEN1KMT2AALDH1A1
SCHEMBL23787618 0.84 ALDH1A1 (0.63) ENPP2PHLPP2MEN1KMT2AALDH1A1
SCHEMBL23787789 0.84 ALDH1A1 (0.51) ENPP2PHLPP2MEN1KMT2AALDH1A1
SCHEMBL23787688 0.83 ENPP2 (0.63) ENPP2PHLPP2MEN1KMT2AALDH1A1
SCHEMBL23787582 0.83 ENPP2 (0.42) ENPP2PHLPP2MEN1KMT2AALDH1A1
SCHEMBL23787628 0.82 ALDH1A1 (0.42) ENPP2PHLPP2MEN1KMT2AALDH1A1
SCHEMBL23787734 0.81 ENPP2 (0.50) ENPP2PHLPP2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 ENPP2 2691/4885PHLPP2 1195/4885MEN1 2015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback